Discontinuation report BRETYLIUM TOSYLATE INJECTION USP

Last updated on 2017-12-06 History
Report ID 31958
Drug Identification Number 02185377
Brand name BRETYLIUM TOSYLATE INJECTION USP
Common or Proper name bretylium
Company Name SANDOZ CANADA INCORPORATED
Active Ingredient(s) BRETYLIUM TOSYLATE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 5 x 10ML VIALS
ATC code C01BD
ATC description ANTIARRHYTHMICS, CLASS I AND III
Reason for discontinuation Manufacturing issues
Anticipated discontinuation date
Actual discontinuation date 2017-12-04
Remaining supply date 2017-12-15
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2017-12-06 French Compare
v1 2017-12-06 English Compare